Peter Riedell, MD

Articles by Peter Riedell, MD
Peter Riedell, MD, Discusses Liso-cel Research for LBCL at ASH 2023
Peter Riedell, MDAggressive B-Cell Lymphoma | December 12, 2023
Polatuzumab-based bridging was associated with high overall response rate and complete response rate.
View More

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    Editorial Board

    About Us

    Terms of Use

    Advertising

    Privacy Policy

    Our Network

    MashupMD

    GU Oncology Now

    Cancer Nursing Today

    Urban Health Today

    DocWire News

    Connect

    eNewsletters

    Calendar of Events

    Contact Us

    Contribute

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |